Sleep Aid Side Effects: Common, Serious & Long-Term

Quick Answer

Sleep aids like zolpidem (Ambien) carry an FDA black box warning for dangerous complex sleep behaviors — including sleep-driving and sleep-eating — with no memory of the event; the FDA also lowered recommended doses after finding next-morning impairment, particularly in women. Trazodone is not a controlled substance but carries a rare risk of priapism, while melatonin's main concerns are daytime grogginess and circadian disruption with misuse.

Overview

Sleep aids span a wide range of drug classes: zolpidem (Ambien) is a non-benzodiazepine sedative-hypnotic (Schedule IV); trazodone is an antidepressant with strong sedating properties used off-label for insomnia; and melatonin is an OTC supplement that mimics the body's natural sleep hormone. Their side effect profiles differ substantially, though next-day drowsiness and impairment are common threads.

Understanding the specific risks of each agent helps patients make informed decisions with their healthcare provider and recognize symptoms that require prompt attention.

Common Side Effects

Next-Day Drowsiness and Impairment

All three agents can cause residual sedation that extends into the morning. This is most clinically significant with zolpidem, particularly extended-release formulations. The FDA specifically investigated next-morning blood levels and found that many patients — especially women — retain enough zolpidem in their system the following morning to impair driving performance, even when they feel awake and alert. Based on these findings, the FDA reduced recommended starting doses for women.

Trazodone can also cause morning grogginess ("sleep hangover"), especially when taken close to waking time. Melatonin's residual sedation is generally milder but can be noticeable, particularly at higher doses or when taken at the wrong time relative to sleep.

Dizziness and Coordination Problems

Zolpidem and trazodone both increase fall risk, particularly in elderly patients who may get up during the night. Dizziness, unsteady gait, and impaired balance are among the most practically significant side effects in this population, as falls can result in hip fractures and serious injury.

Headache and Gastrointestinal Effects

Headache is reported with all three agents. Trazodone commonly causes dry mouth and mild gastrointestinal complaints. Melatonin is occasionally associated with nausea at higher doses.

Serious Side Effects

⚠ The following serious effects require prompt medical attention or immediate discontinuation under prescriber guidance.

Complex Sleep Behaviors — Zolpidem (Black Box Warning)

The FDA's most serious warning on zolpidem and related sedative-hypnotics covers complex sleep behaviors: activities performed while in a state of partial arousal, with no subsequent memory of the event. Documented examples include sleepwalking, sleep-driving (getting in a car and driving while not fully awake), sleep-eating (preparing and eating food with no recollection), making phone calls, and engaging in sexual activity. These behaviors have resulted in injuries and deaths. The FDA requires that zolpidem be stopped immediately if a complex sleep behavior occurs, and that the prescriber be notified.

Risk factors include higher doses, alcohol or other CNS depressants taken on the same night, and extended-release formulations.

Rebound Insomnia on Discontinuation

When zolpidem is stopped after regular use, sleep often worsens temporarily — sometimes to a degree worse than the original insomnia. This rebound effect is a withdrawal phenomenon reflecting the brain's adaptation to the drug's presence. It typically lasts several nights to a week and can be minimized with gradual tapering rather than abrupt discontinuation. Rebound insomnia can create a psychological cycle that makes it difficult to stop the medication.

Priapism — Trazodone

Trazodone is a known cause of priapism — a prolonged, painful erection unrelated to sexual arousal that does not resolve on its own. This is a medical emergency: if an erection lasts more than 2–4 hours, emergency treatment is required to prevent permanent damage. The risk is low but not negligible, and patients should be counseled about this possibility before starting trazodone.

Long-Term Effects

Tolerance and dependence (zolpidem): Zolpidem is classified as Schedule IV due to its potential for dependence. Tolerance (requiring more of the drug for the same effect) and physical dependence can develop with regular use. Guidelines generally recommend limiting use to short-term therapy, though this is frequently not followed in practice.
Cognitive effects in elderly patients: Long-term benzodiazepine and sedative-hypnotic use is associated with increased risk of cognitive impairment and dementia in older adults. Zolpidem is included in the Beers Criteria — a list of medications considered potentially inappropriate in older adults — due to these risks.
Disruption of sleep architecture: Zolpidem alters normal sleep stages, reducing slow-wave (deep) sleep. While it may increase total sleep time in the short term, the quality of that sleep may be diminished.
Circadian disruption (melatonin): Using melatonin at the wrong time of day, or at very high doses, can shift circadian rhythm in unintended ways. Most OTC formulations in the US contain far higher doses than those used in clinical research, where doses as low as 0.5 mg have shown efficacy.

Who Is Most at Risk

Women taking zolpidem — metabolize the drug more slowly, leading to higher next-morning blood levels and impaired driving
Elderly patients — at heightened risk for falls, cognitive effects, and complex sleep behaviors
Patients combining zolpidem with alcohol or CNS depressants — dramatically increased risk of complex sleep behaviors and respiratory depression
Anyone who needs to drive within 7–8 hours of taking zolpidem — next-morning impairment is a documented safety concern
Men on trazodone — at risk for priapism; should report any prolonged erection immediately

Managing Side Effects

Cognitive behavioral therapy for insomnia (CBT-I) is considered the first-line treatment for chronic insomnia and does not carry medication side effects. If a sleep aid is needed, using the lowest effective amount for the shortest duration reduces risk. Never combine prescription sleep aids with alcohol.

Do not take zolpidem unless you have a full 7–8 hours available for sleep
Avoid alcohol on any night you take a prescription sleep aid
Tell your prescriber about all other medications — especially CNS depressants — before starting a sleep aid
If you experience any behavior during sleep that you cannot remember, stop the medication and contact your prescriber immediately
Men should seek emergency care immediately if an erection lasts more than 2–4 hours while taking trazodone
Do not stop zolpidem abruptly after regular use — ask your prescriber about gradual tapering

Frequently Asked Questions

What is the FDA black box warning on zolpidem about?

The FDA added a black box warning to zolpidem and other sedative-hypnotics in 2019 for complex sleep behaviors — activities performed while not fully awake, including sleepwalking, sleep-driving, making phone calls, preparing and eating food, and having sex, with no memory of the event. These behaviors can be dangerous or fatal. The warning advises that zolpidem should be stopped immediately if a complex sleep behavior occurs.

Why does the FDA recommend lower doses of zolpidem for women?

Women metabolize zolpidem more slowly than men, leading to higher blood levels in the morning that can impair driving ability even when the person feels awake. Based on this finding, the FDA lowered the recommended starting doses for women. Next-morning impairment is a particular concern for anyone who needs to drive or operate machinery within 7–8 hours of taking zolpidem.

What is rebound insomnia and how long does it last?

Rebound insomnia refers to a temporary worsening of sleep that occurs when a sedative-hypnotic like zolpidem is stopped, particularly after regular use. Sleep may be worse for several nights than it was before treatment started. This is a withdrawal phenomenon, not a return of the underlying condition, and typically resolves within a few days to a week. Gradual tapering under prescriber guidance can minimize rebound effects.

Is trazodone habit-forming?

Trazodone is not classified as a controlled substance and does not carry the same dependence risk as zolpidem or benzodiazepines. However, some people develop psychological reliance on it for sleep. It also carries a rare but serious risk of priapism (prolonged, painful erection requiring emergency treatment), which should be reported immediately if it occurs.

Related Drugs

⚠ This article is for informational purposes only and does not constitute medical advice. Always consult your prescriber or pharmacist before starting, stopping, or changing any sleep medication.